Pembrolizumab with or without chemotherapy among older adults with advanced lung adenocarcinoma: a national, nonrandomized open-label phase II trial (Alliance A171901). uri icon

authors

  • Melisa L. Wong, MD, MAS
  • Homan, Sherri
  • Finnes, Heidi D
  • Waqar, Saiama
  • Jatoi, Aminah
  • Lee, Minji K
  • Kour, Oudom
  • Satele, Daniel
  • Presley, Carolyn J
  • Le-Rademacher, Jennifer
  • Ojelabi, Michael
  • Chow, Selina
  • Stinchcombe, Thomas E

publication date

  • May 20, 2026